Astellas Pharma Korea Officially Launched

Published: 2005-04-07 06:57:00

Updated: 2005-04-07 06:57:00

The merger between two Japanese pharmaceutical organizations, Yamanouchi Pharmaceutical Co. Ltd and Fujisawa Pharmaceutical Co. Ltd, has formed the new commercial entity under the name Astellas Pharma Korea, Inc. in the domestic market, starting its full operations effective April 1st.

Under t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK